Rahlfs Capital
PFE icon

Rahlfs Capital’s Pfizer PFE Stock Holding History

Rahlfs Capital’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.22M Buy
42,620
+4,934
+13% +$131K 0.81% 36
2026
Q2 		$907K Hold
37,686
– – 0.67% 40
2026
Q1 		$1.06M Hold
37,686
– – 0.78% 41
2025
Q4 		$938K Sell
37,686
-867
-2% -$21.9K 0.73% 38
2025
Q3 		$982K Sell
38,553
-800
-2% -$19.7K 0.78% 40
2025
Q2 		$954K Buy
39,353
+900
+2% +$21K 0.87% 37
2025
Q1 		$974K Sell
38,453
-1,500
-4% -$39.3K 0.98% 34
2024
Q4 		$1.06M Buy
+39,953
New +$1.08M 1.05% 28

Other funds holding PFE

State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $296B AUM 23.14% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $142B AUM 43.93% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return

Rahlfs Capital's PFE Position: Q3 2026 in Review

Rahlfs Capital increased its Pfizer (PFE) stake by 13% in Q3 2026, buying an estimated $131K and bringing the position to 42,620 shares worth $1.22M. The position accounts for 0.81% of the portfolio, ranked #36.

Rahlfs Capital first reported a position in PFE in Q4 2024 and has held it in 8 quarters since. 2,277 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

  • Rahlfs Capital held 42,620 shares of Pfizer worth $1.22M as of Q3 2026.
  • Rahlfs Capital bought 4,934 Pfizer shares in Q3 2026, an estimated $131K.
  • Pfizer made up 0.81% of Rahlfs Capital's portfolio in Q3 2026, its #36 holding.
  • Rahlfs Capital first reported a position in Pfizer in Q4 2024 and has held it in 8 quarters since.
  • 2,277 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on Rahlfs Capital's 13F filing for Q3 2026, filed 23 Oct 2026.